Genetic Obesity Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Genetic Obesity Drug Market Definition
1.2 Market Segments
1.2.1 Market by Drug Type
1.2.2 Market by Application
1.3 Global Genetic Obesity Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genetic Obesity Drug Overall Market Size
2.1 Global Genetic Obesity Drug Market Size: 2021 VS 2028
2.2 Global Genetic Obesity Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genetic Obesity Drug Players in Global Market
3.2 Top Global Genetic Obesity Drug Companies Ranked by Revenue
3.3 Global Genetic Obesity Drug Revenue by Companies
3.4 Top 3 and Top 5 Genetic Obesity Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genetic Obesity Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genetic Obesity Drug Players in Global Market
3.6.1 List of Global Tier 1 Genetic Obesity Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Genetic Obesity Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Drug Type - Global Genetic Obesity Drug Market Size Markets, 2021 & 2028
4.1.2 Sibutramine
4.1.3 Orlistat
4.1.4 Sympathomimetic Drugs
4.1.5 Receptors Antagonists
4.1.6 Others
4.2 By Drug Type - Global Genetic Obesity Drug Revenue & Forecasts
4.2.1 By Drug Type - Global Genetic Obesity Drug Revenue, 2017-2022
4.2.2 By Drug Type - Global Genetic Obesity Drug Revenue, 2023-2028
4.2.3 By Drug Type - Global Genetic Obesity Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genetic Obesity Drug Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Genetic Obesity Drug Revenue & Forecasts
5.2.1 By Application - Global Genetic Obesity Drug Revenue, 2017-2022
5.2.2 By Application - Global Genetic Obesity Drug Revenue, 2023-2028
5.2.3 By Application - Global Genetic Obesity Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Genetic Obesity Drug Market Size, 2021 & 2028
6.2 By Region - Global Genetic Obesity Drug Revenue & Forecasts
6.2.1 By Region - Global Genetic Obesity Drug Revenue, 2017-2022
6.2.2 By Region - Global Genetic Obesity Drug Revenue, 2023-2028
6.2.3 By Region - Global Genetic Obesity Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Genetic Obesity Drug Revenue, 2017-2028
6.3.2 US Genetic Obesity Drug Market Size, 2017-2028
6.3.3 Canada Genetic Obesity Drug Market Size, 2017-2028
6.3.4 Mexico Genetic Obesity Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Genetic Obesity Drug Revenue, 2017-2028
6.4.2 Germany Genetic Obesity Drug Market Size, 2017-2028
6.4.3 France Genetic Obesity Drug Market Size, 2017-2028
6.4.4 U.K. Genetic Obesity Drug Market Size, 2017-2028
6.4.5 Italy Genetic Obesity Drug Market Size, 2017-2028
6.4.6 Russia Genetic Obesity Drug Market Size, 2017-2028
6.4.7 Nordic Countries Genetic Obesity Drug Market Size, 2017-2028
6.4.8 Benelux Genetic Obesity Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Genetic Obesity Drug Revenue, 2017-2028
6.5.2 China Genetic Obesity Drug Market Size, 2017-2028
6.5.3 Japan Genetic Obesity Drug Market Size, 2017-2028
6.5.4 South Korea Genetic Obesity Drug Market Size, 2017-2028
6.5.5 Southeast Asia Genetic Obesity Drug Market Size, 2017-2028
6.5.6 India Genetic Obesity Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Genetic Obesity Drug Revenue, 2017-2028
6.6.2 Brazil Genetic Obesity Drug Market Size, 2017-2028
6.6.3 Argentina Genetic Obesity Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genetic Obesity Drug Revenue, 2017-2028
6.7.2 Turkey Genetic Obesity Drug Market Size, 2017-2028
6.7.3 Israel Genetic Obesity Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Genetic Obesity Drug Market Size, 2017-2028
6.7.5 UAE Genetic Obesity Drug Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Corporate Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Genetic Obesity Drug Major Product Offerings
7.1.4 Pfizer, Inc. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.1.5 Pfizer, Inc. Key News
7.2 Sanofi.
7.2.1 Sanofi. Corporate Summary
7.2.2 Sanofi. Business Overview
7.2.3 Sanofi. Genetic Obesity Drug Major Product Offerings
7.2.4 Sanofi. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.2.5 Sanofi. Key News
7.3 Tonghua Dongbao Pharmaceutical Co., Ltd.
7.3.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Corporate Summary
7.3.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Business Overview
7.3.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Major Product Offerings
7.3.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.3.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Key News
7.4 Biocon.
7.4.1 Biocon. Corporate Summary
7.4.2 Biocon. Business Overview
7.4.3 Biocon. Genetic Obesity Drug Major Product Offerings
7.4.4 Biocon. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.4.5 Biocon. Key News
7.5 Adocia
7.5.1 Adocia Corporate Summary
7.5.2 Adocia Business Overview
7.5.3 Adocia Genetic Obesity Drug Major Product Offerings
7.5.4 Adocia Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.5.5 Adocia Key News
7.6 GlaxoSmithKline Plc.
7.6.1 GlaxoSmithKline Plc. Corporate Summary
7.6.2 GlaxoSmithKline Plc. Business Overview
7.6.3 GlaxoSmithKline Plc. Genetic Obesity Drug Major Product Offerings
7.6.4 GlaxoSmithKline Plc. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Plc. Key News
7.7 Novo Nordisk A/S.
7.7.1 Novo Nordisk A/S. Corporate Summary
7.7.2 Novo Nordisk A/S. Business Overview
7.7.3 Novo Nordisk A/S. Genetic Obesity Drug Major Product Offerings
7.7.4 Novo Nordisk A/S. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.7.5 Novo Nordisk A/S. Key News
7.8 Oramed Pharmaceuticals, Inc
7.8.1 Oramed Pharmaceuticals, Inc Corporate Summary
7.8.2 Oramed Pharmaceuticals, Inc Business Overview
7.8.3 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Major Product Offerings
7.8.4 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.8.5 Oramed Pharmaceuticals, Inc Key News
7.9 Wockhardt.
7.9.1 Wockhardt. Corporate Summary
7.9.2 Wockhardt. Business Overview
7.9.3 Wockhardt. Genetic Obesity Drug Major Product Offerings
7.9.4 Wockhardt. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.9.5 Wockhardt. Key News
7.10 Eli Lilly and Company.
7.10.1 Eli Lilly and Company. Corporate Summary
7.10.2 Eli Lilly and Company. Business Overview
7.10.3 Eli Lilly and Company. Genetic Obesity Drug Major Product Offerings
7.10.4 Eli Lilly and Company. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.10.5 Eli Lilly and Company. Key News
7.11 Merck & Co., Inc.
7.11.1 Merck & Co., Inc. Corporate Summary
7.11.2 Merck & Co., Inc. Business Overview
7.11.3 Merck & Co., Inc. Genetic Obesity Drug Major Product Offerings
7.11.4 Merck & Co., Inc. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.11.5 Merck & Co., Inc. Key News
7.12 Julphar.
7.12.1 Julphar. Corporate Summary
7.12.2 Julphar. Business Overview
7.12.3 Julphar. Genetic Obesity Drug Major Product Offerings
7.12.4 Julphar. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.12.5 Julphar. Key News
7.13 Bristol-Myers Squibb Company.
7.13.1 Bristol-Myers Squibb Company. Corporate Summary
7.13.2 Bristol-Myers Squibb Company. Business Overview
7.13.3 Bristol-Myers Squibb Company. Genetic Obesity Drug Major Product Offerings
7.13.4 Bristol-Myers Squibb Company. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.13.5 Bristol-Myers Squibb Company. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Genetic Obesity Drug Market Opportunities & Trends in Global Market
Table 2. Genetic Obesity Drug Market Drivers in Global Market
Table 3. Genetic Obesity Drug Market Restraints in Global Market
Table 4. Key Players of Genetic Obesity Drug in Global Market
Table 5. Top Genetic Obesity Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Genetic Obesity Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Genetic Obesity Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Genetic Obesity Drug Product Type
Table 9. List of Global Tier 1 Genetic Obesity Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genetic Obesity Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Drug Type ? Global Genetic Obesity Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Drug Type - Genetic Obesity Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Drug Type - Genetic Obesity Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Genetic Obesity Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Genetic Obesity Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Genetic Obesity Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Genetic Obesity Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Genetic Obesity Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Genetic Obesity Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Genetic Obesity Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Genetic Obesity Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Genetic Obesity Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Genetic Obesity Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Genetic Obesity Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Genetic Obesity Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Genetic Obesity Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Genetic Obesity Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Genetic Obesity Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Genetic Obesity Drug Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer, Inc. Corporate Summary
Table 31. Pfizer, Inc. Genetic Obesity Drug Product Offerings
Table 32. Pfizer, Inc. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi. Corporate Summary
Table 34. Sanofi. Genetic Obesity Drug Product Offerings
Table 35. Sanofi. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 36. Tonghua Dongbao Pharmaceutical Co., Ltd. Corporate Summary
Table 37. Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Product Offerings
Table 38. Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 39. Biocon. Corporate Summary
Table 40. Biocon. Genetic Obesity Drug Product Offerings
Table 41. Biocon. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 42. Adocia Corporate Summary
Table 43. Adocia Genetic Obesity Drug Product Offerings
Table 44. Adocia Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Plc. Corporate Summary
Table 46. GlaxoSmithKline Plc. Genetic Obesity Drug Product Offerings
Table 47. GlaxoSmithKline Plc. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 48. Novo Nordisk A/S. Corporate Summary
Table 49. Novo Nordisk A/S. Genetic Obesity Drug Product Offerings
Table 50. Novo Nordisk A/S. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 51. Oramed Pharmaceuticals, Inc Corporate Summary
Table 52. Oramed Pharmaceuticals, Inc Genetic Obesity Drug Product Offerings
Table 53. Oramed Pharmaceuticals, Inc Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 54. Wockhardt. Corporate Summary
Table 55. Wockhardt. Genetic Obesity Drug Product Offerings
Table 56. Wockhardt. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 57. Eli Lilly and Company. Corporate Summary
Table 58. Eli Lilly and Company. Genetic Obesity Drug Product Offerings
Table 59. Eli Lilly and Company. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 60. Merck & Co., Inc. Corporate Summary
Table 61. Merck & Co., Inc. Genetic Obesity Drug Product Offerings
Table 62. Merck & Co., Inc. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 63. Julphar. Corporate Summary
Table 64. Julphar. Genetic Obesity Drug Product Offerings
Table 65. Julphar. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
Table 66. Bristol-Myers Squibb Company. Corporate Summary
Table 67. Bristol-Myers Squibb Company. Genetic Obesity Drug Product Offerings
Table 68. Bristol-Myers Squibb Company. Genetic Obesity Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Genetic Obesity Drug Segment by Drug Type in 2021
Figure 2. Genetic Obesity Drug Segment by Application in 2021
Figure 3. Global Genetic Obesity Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Genetic Obesity Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Genetic Obesity Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genetic Obesity Drug Revenue in 2021
Figure 8. By Drug Type - Global Genetic Obesity Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Genetic Obesity Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Genetic Obesity Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Genetic Obesity Drug Revenue Market Share, 2017-2028
Figure 12. US Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Genetic Obesity Drug Revenue Market Share, 2017-2028
Figure 16. Germany Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Genetic Obesity Drug Revenue Market Share, 2017-2028
Figure 24. China Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Genetic Obesity Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Genetic Obesity Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Genetic Obesity Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer, Inc. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biocon. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Adocia Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Plc. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novo Nordisk A/S. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Oramed Pharmaceuticals, Inc Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Wockhardt. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eli Lilly and Company. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck & Co., Inc. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Julphar. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Bristol-Myers Squibb Company. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
